Doug Friedman | Chief Executive Officer

Douglas Friedman is CEO of BioMADE. In founding BioMADE, Doug seeks to secure the growth of the U.S. industrial biomanufacturing ecosystem and advance the non-health bioeconomy. He also serves as consultant (special government employee) at the White House Office of Science & Technology Policy focused on a broad range of policy matters in non-health biotechnology and biomanufacturing as drivers for economic growth and opportunities in national security.  His primary scientific and technical interests lie in the fields of synthetic biology, industrial biomanufacturing, and modern biotechnology. Doug's policy interests include development of sustainable biotechnology, safeguarding the bioeconomy, and accelerating technical advancement by building diverse, robust community partnerships. He regularly serves as a subject matter expert on emerging biotechnologies, biotechnology policy, and national security topics at the interface of the biological and chemical sciences, including the Department of Commerce, Bureau of Industry & Security Materials and Equipment Technical Advisory Committee. Prior to BioMADE, Doug was the founding Executive Director and President of Engineering Biology Research Consortium (EBRC).  Prior to EBRC, he was a study director and senior program officer with the Board on Chemical Sciences and Technology at the National Academies of Sciences, Engineering, and Medicine where his focus was at the interface of chemistry and biology with a frequent focus on national security matters. Earlier in his career, Doug performed research in physical organic chemistry and chemical biology in academia and industry. He earned a Ph.D. in Chemistry from Northwestern University and a B.S. in Chemical Biology from the University of California, Berkeley.